News

Brookfield Corporation Announces C$200 Million Preferred Share Offering

Brookfield Corporation Announces C$200 Million Preferred Share Offering

Brookfield Corporation's Strategic Financing Move

Brookfield Corporation, a renowned global investment firm, has recently made an announcement that is generating significant attention within the investment community. The company has agreed to issue 8 million Class A Preference Shares, Series 54, on a bought deal basis, aiming to raise C$200 million. This offering is led by a coalition of prominent underwriters, including Scotiabank, BMO Capital Markets, CIBC Capital Markets, and RBC Capital Markets, contributing to the transaction's credibility.

Details of the Offering

The Preferred Shares, Series 54, which will be sold at C$25.00 per share, come with a cumulative quarterly dividend fixed at an attractive 5.65% annually for an initial span that concludes on December 31, 2030. After this period, the dividend rate is set to potentially increase every five years, determined by the greater of the 5-year Government of Canada bond yield plus 2.80% or maintaining that 5.65% rate. This feature not only offers fairness for investors but also aligns with Brookfield's commitment to provide value to its shareholders.

Redemption Plans for Existing Shares

In conjunction with this offering, Brookfield Corporation plans to utilize the net proceeds to redeem at least C$200 million of its existing Cumulative Class A Preference Shares, Series 44. The redemption is scheduled for December 31, 2025. Should the underwriters' option be fully exercised, which allows for the purchase of an additional 2 million shares, Brookfield intends to fully redeem all Series 44 shares as well. For current holders, this means a return of C$25.00 per share, alongside a quarterly dividend of C$0.3125 payable on the redemption date.

Prospective Investors and Regulatory Information

Investors interested in this offering should take note that, while the offering is accessible to residents across Canada, strict regulations prevent its sale in the U.S. without proper registration. Hence, it is crucial for prospective investors to thoroughly read through the provided Base Shelf Prospectus and the corresponding Prospectus Supplement before making any investment commitments. These documents will be accessible on the Canadian investment platform SEDAR+ within a few business days following this announcement.

About Brookfield Corporation

Brookfield Corporation is distinguished as a leading global investment entity, prioritizing the creation of long-lasting wealth for diverse clients, including institutions and individuals. With a robust focus on alternative asset management, wealth solutions, and operating businesses in renewable power, infrastructure, and real estate, Brookfield consistently delivers impressive annualized returns exceeding 15% over the past 30 years. Their adept management approach, paired with extensive operational expertise, positions them uniquely to leverage a plethora of investment prospects.

Building Long-Term Wealth

Central to Brookfield's success is what they term the Brookfield Ecosystem. This operational framework allows various divisions within the company to synergize effectively, ensuring that all components benefit from their interconnectedness. Investing through Brookfield means engaging with a firm optimized for sustainable growth and strategic opportunity extraction.

Contact Details

For any inquiries, individuals can reach out to the Brookfield team:

Media Contact

Kerrie McHugh

Phone: (212) 618-3469

Email: kerrie.mchugh@brookfield.com

Investor Relations Contact

Katie Battaglia

Phone: (416) 359-8544

Email: katie.battaglia@brookfield.com

Frequently Asked Questions

What is the purpose of the C$200 million offering?

The offering aims to raise funds for redeeming existing preference shares and enhancing financial strategies.

Who are the underwriters involved in this offering?

Scotiabank, BMO Capital Markets, CIBC Capital Markets, and RBC Capital Markets are among the key underwriters.

What dividends will the new preference shares offer?

The new Series 54 shares will provide a fixed dividend of 5.65% annually for an initial period.

When is the expected redemption date for the Series 44 shares?

The redemption for Series 44 shares is scheduled for December 31, 2025.

How can investors access the prospectus documents?

Investors can view the Base Shelf Prospectus and Prospectus Supplement on SEDAR+ shortly after the announcement.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Infotech's 2026 Report Crowns PSA Software Leaders

Updated Category News Views 20

Spotlight on PSA Trailblazers It's 2026, and Infotech has dropped its latest bombshell—the Professional Services Automation Data Quadrant Report. This ain't just your run-of-the-mill software rankings; it's a peek into tools that could make or break project management for service-oriented businesses. Five top dogs, RocketLane, Wrike, Accelo, SAP Professional Services...

Continue Reading
NORROY's Radiopharma Innovations: EANM Highlights

Updated Category News Views 93

Breaking Ground: NORROY's Radiopharmaceutical Innovations If you thought the radiopharmaceutical game was stuck in the same ol' rut, NORROY Bioscience just flipped the script. Standing out at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26) in Vienna, they trotted out enough breakthroughs to make you wonder if they're secretly running on...

Continue Reading
AlphaESS Secures Fifth Tier 1 Status Amid Growth

Updated Category News Views 177

AlphaESS: Consistency Breeds Success Can't ignore a company that keeps hitting the marks quarter after quarter, kid. AlphaESS just bagged its fifth consecutive Tier 1 status from BloombergNEF for Q4 2026—that's no joke in the buzzing world of energy storage. What makes this outfit tick? It's not just sticking to the same old script; they keep leveling up while everyone...

Continue Reading
GomSpace Eyes SEK 1.6 Billion Revenue by 2030

Updated Category News Views 135

Cracking Open GomSpace's Q3 Gains You don't just stumble upon profitability in this market; that's for sure. GomSpace, however, seems to have a knack for finding its stride amidst the chaos. In their latest earnings report, it looks like they're not just coasting—they're powering through with profitable growth in the third quarter. Who would have thought? These folks...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 93

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
KT&G Soars with Record Profits, Aggressive Share Buybacks

Updated Category News Views 73

KT&G Climbs to New Heights with Record-Setting Q3 If you're eyeballing the markets like a hawk, KT&G (KRX: 033780) just gave you something to squawk about. In the world of stocks, milestones are few and far between, but KT&G is handing out milestones like candy in Q3. They rolled out their numbers for the quarter, and let me tell ya, this was no pie-in-the-sky nonsense....

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 73

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Magnolia Data Breach: Legal Stakes Loom for Seniors

Updated Category News Views 192

Elderly Residents at Risk After Data Breach Well, here we go again — another day, another data breach debacle. This time, it's Magnolia Management putting senior residents' sensitive information on a silver platter for potential cyber intruders. We're talking names, Social Security numbers, and medical records — the whole shebang. When you're handling such crucial...

Continue Reading
Multi-Society Panel Boosts Vaccine Guidance Clarity

Updated Category News Views 23

Vaccination Confusion: Could Clarity Finally Be Here? Here's the scoop, folks. In the swirling mess of immunization advice, a coalition of top medical societies has thrown a lifeline to clinicians. If you're drowning in conflicting vaccine guidance, this panel's unified stance might just be your life raft. The Coalition Forces of Immunization We have the Vaccine Guidance...

Continue Reading
Bram Schot Steers Marelli Through Chapter 11 Resurgence

Updated Category News Views 97

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Boldyn Networks Achieves Major Player Status in Private 5G Market

Updated Category News Views 163

Boldyn Networks Achieves Major Recognition in Private 5G Sector Boldyn Networks, a global leader in private networks and shared communications infrastructure, has made waves in the telecommunications industry with its recent recognition as a Major Player in the IDC MarketScape: European Enterprise Private 5G Solutions 2025 Vendor Assessment. This validation reflects...

Continue Reading
LinkSquares Debuts All-Agentic CLM Platform for Legal Teams

Updated Category News Views 16

LinkSquares: A Game Changer for Contract Management In the world of legal and business operations, few things eat away at patience—let alone profits—like the cumbersome dance of contract management. Enter LinkSquares, strutting onto the stage with its new all-agentic CLM platform, promising to turn this often painful process into a streamlined operation that saves...

Continue Reading
Sanctuary Medicinals Triumphs at NECANN Cup with Recognition

Updated Category News Views 216

Sanctuary Medicinals Shines at NECANN Cup Boston 2025 Sanctuary Medicinals proudly celebrates a remarkable achievement at the 6th Annual NECANN Cup Boston. The company earned the impressive title of 4th place in the competitive Solvent Concentrates category. This accolade showcases Sanctuary Medicinals' unwavering commitment to excellence, innovation, and quality within...

Continue Reading
Patients Continue Obesity Treatments as Coverage Shrinks

Updated Category News Views 174

The Growing Challenge of Obesity Drug Coverage For many individuals battling obesity, the struggle is not just about losing weight. It’s also about bearing the financial burden of treatments. With increasing limitations from insurers regarding weight-loss drugs, patients are often forced to alter their lifestyles significantly. Vacations are postponed, dining out is...

Continue Reading
Humacyte, Inc. Investors Urged to Act Before Class Action Deadline

Updated Category News Views 123

Important Attention for Humacyte, Inc. Investors As an investor in Humacyte, Inc., it’s essential to stay informed about legal opportunities that could impact your investments. The Rosen Law Firm, known for its dedication to protecting investor rights, is reminding those who purchased Humacyte securities during a specified period about an important upcoming deadline....

Continue Reading